A Scoping Review Of Alzheimers Disease Hypotheses: The Case For A Multi-Factorial Theory
Duchesne, S.; Rousseau, L.-S.; Belzile, F.; Welsh, L.-A.; Cournoyer, B.; Arseneau, M.; Lapierre, V.; Poulin, S.-M.; Potvin, O.; Hudon, C.
Show abstract
IntroductionThere is a common agreement that Alzheimers disease (AD) is inherently complex; otherwise, a general disagreement remains on its etiological underpinning, with numerous alternative hypotheses having been proposed. MethodsWe performed a scoping review of 105 original manuscripts describing hypotheses and theories of AD published in the past decades, characterized them as having a single or multifactorial focus, and tracked their impact. ResultsThree stages can be discerned in terms of hypotheses generation, with three quarter of studies proposing a hypothesis characterized as being single-focus. The most important theoretical groupings were the Amyloid group, followed by Metabolism and Mitochondrial dysfunction, then Cerebrovascular. Lately, evidence towards Genetics and especially Gut/Brain interactions came to the fore. DiscussionWhen viewed together, these multi-faceted reports reinforce the notion that AD affects multiple sub-cellular, cellular, anatomical, and physiological systems at the same time but at varying degree between individuals. A major impediment remains provide a comprehensive view of all these systems and their interactions to manage its inherent complexity. RESEARCH IN CONTEXTO_LIWe propose a scoping review of 105 original manuscripts describing hypotheses and theories of Alzheimers disease (AD) that have been published in the past decades, characterized as having a single or multifactorial focus. C_LIO_LIWe found that three quarter of studies proposed a hypothesis characterized as being single-focus (77/105), with the most important theoretical groupings being the Amyloid group, followed by Metabolism and Mitochondrial dysfunction, then Cerebrovascular. Three stages can be discerned in terms of hypotheses generation. The first phase ([~]1980-1995) included the establishment of the main thrusts that have endured to this day (Amyloid, Glial, Infection, Inflammation, Metabolism, Oxidative stress, and Proteinopathies hypotheses; multifactorality; and neurotoxicity). In the second phase (1995-2005), the importance of the Cerebrovasculature, Mitochondrial dysfunction, and Neurotransmitters were recognized. Lately (2005-2020), evidence towards Genetics (outside of the autosomal dominant form of AD), and especially Gut/Brain interactions came to the fore. C_LIO_LIWhen viewed together, these multi-faceted reports reinforce the notion that AD affects multiple sub-cellular, cellular, anatomical, and physiological systems at the same time but at varying degree between individuals. A major impediment remains provide a comprehensive view of all these systems and their interactions to manage its inherent complexity. C_LI HIGHLIGHTS- We propose a scoping review of hypotheses and theories for Alzheimers disease (AD) - Out of over 11,000 abstracts, we reviewed 105 articles, separated as having a single-focus or multi-factorial approach - The diversity of reports calls for an integrative view of AD in order to encompass its inherent complexity
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- CSF and PET biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis 95%
- Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities 94%
- Unbiased data-driven analysis of five amyloid-beta peptides for biomarker investigations in familial Alzheimer's disease 93%
Similar papers in this journal
- Alzheimer Disease Neuropathological Comorbidities Are Common in the Younger-Old 95%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 94%
- Metabolites associated with early cognitive changes implicated in Alzheimer’s disease 94%
Similar papers in this journal
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 94%
- A conformational variant of p53 (U-p53 AZ ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s disease 94%
- Identifying Proteomic Prognostic Markers for Alzheimer’s Disease with Survival Machine Learning: the Framingham Heart Study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.